AIM ImmunoTech

AIMNYSE United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$7.912 M

$0.29 +5.39%

Close of 7 Aug 2026

Revenue

$88.0K

#3615 by revenue

Earnings

-$14.0M

Loss-making

Shares outstanding

30,442,139

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#148In8bioINAB$9.64M
#149Creative Medical TechnologyCELZ$9.36M
#150AIM ImmunoTechAIM$7.91M
#151VivoSim LabsVIVS$7.85M
#152CurisCRIS$7.83M

Where these numbers come from

Share counts and financials for AIM ImmunoTech are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.